FDA NDC Directory · JSON-LD · Markdown

Dexrazoxane

NDC 72611-716 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameDexrazoxane for Injection
Labeler / ManufacturerAlmaject, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207321
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDEXRAZOXANE HYDROCHLORIDE (500 mg/50mL)
Marketing started20220601
Package count1

External sources

Source: openFDA. Public-domain (CC0).